Due to their lack of association with hypoglycemia, positive effects on satiety and weight loss, and infrequency of administration, these GLP-1 analogues are now the first injectable medication of choice indicated by ADA guidelines for type-2 diabetics
Some protocols use subcutaneous injections a tiny needle just under the skin, similar to insulin
If the provider documents peripheral neuropathy, distal symmetric polyneuropathy, or stocking-glove distribution, E11.42 is the appropriate code
The Qsymia Plan for Weight Loss: What Treatment Looks Like A typical Qsymia treatment plan in a structured medical weight loss program includes: Initial evaluation: Medical history, weight history, BMI, comorbidities, current medications, contraindication screening, and baseline labs
Southlake patients in our wellness network reported 2x higher success rates in maintaining losses compared to solo efforts